CA2424623A1 - Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide - Google Patents

Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide Download PDF

Info

Publication number
CA2424623A1
CA2424623A1 CA002424623A CA2424623A CA2424623A1 CA 2424623 A1 CA2424623 A1 CA 2424623A1 CA 002424623 A CA002424623 A CA 002424623A CA 2424623 A CA2424623 A CA 2424623A CA 2424623 A1 CA2424623 A1 CA 2424623A1
Authority
CA
Canada
Prior art keywords
antacid
patient
immunoglobulin
pooled human
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002424623A
Other languages
English (en)
Inventor
Richard Weisbart
Leon Barstow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2424623A1 publication Critical patent/CA2424623A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Selon l'invention, un pool d'immunoglobuline humaine et éventuellement un antiacide peuvent être administrés par voie orale à des patients souffrant d'arthrite rhumatoïde juvénile en vue de traiter l'état pathologique de ces patients. L'administration orale d'un pool d'immunoglobuline humaine conjointement avec un antiacide permet d'obtenir une amélioration clinique marquée en termes de degré d'activité de la maladie chez les patients atteints d'arthrite rhumatoïde juvénile.
CA002424623A 2000-10-06 2001-10-05 Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide Abandoned CA2424623A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68061900A 2000-10-06 2000-10-06
US09/680,619 2000-10-06
PCT/US2001/031240 WO2002028430A2 (fr) 2000-10-06 2001-10-05 Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide

Publications (1)

Publication Number Publication Date
CA2424623A1 true CA2424623A1 (fr) 2002-04-11

Family

ID=24731818

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002424623A Abandoned CA2424623A1 (fr) 2000-10-06 2001-10-05 Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide

Country Status (4)

Country Link
EP (1) EP1355665A2 (fr)
JP (1) JP2004510748A (fr)
CA (1) CA2424623A1 (fr)
WO (1) WO2002028430A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL211753B1 (pl) * 2001-01-30 2012-06-29 Lauridsen Group Zastosowanie koncentratu antygenowo nie-specyficznych immunoglobulin pochodzących z krwi zwierząt i kompozycja farmaceutyczna zawierająca immunoglobuliny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3272680D1 (en) * 1981-05-01 1986-09-25 Miles Lab Oral pharmaceutical composition containing immune globulin
CA2183566A1 (fr) * 1994-02-18 1995-08-24 Yendra Linnau Composition et procede destines a prevenir et traiter les inflammations a l'aide d'immunoglobuline a

Also Published As

Publication number Publication date
EP1355665A2 (fr) 2003-10-29
JP2004510748A (ja) 2004-04-08
WO2002028430A2 (fr) 2002-04-11
WO2002028430A3 (fr) 2003-08-28

Similar Documents

Publication Publication Date Title
US6294171B2 (en) Methods for treating disease states comprising administration of low levels of antibodies
AU781889B2 (en) Method for treatment of symptoms of central nervous system disorders
US20030099635A1 (en) Use of oral gammaglobulin for the treatment of immune-mediated diseases
Aghamohammadi et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency
TW202233234A (zh) 抗前肌生成抑制蛋白／潛伏性肌生成抑制蛋白抗體用於治療脊髓性肌萎縮之用途
CN119923273A (zh) 用于使用FcRn拮抗剂治疗肌炎的方法
US6436401B1 (en) Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
Burakgazi Immunoglobulin treatment in neuromuscular medicine
US6090380A (en) Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin
CA2424623A1 (fr) Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide
CA2370268A1 (fr) Traitement de la polyarthrite rhumatoide de l'adulte par l'administration orale d'immunoglobuline humaine provenant d'un pool de donneurs et d'un antiacide
Enders et al. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat
Cianci et al. Subcutaneous immunoglobulin in infantile chronic inflammatory demyelinating polyneuropathy: a case report
WO2021018191A1 (fr) Méthode de traitement d'une maladie auto-immune par un antagoniste de l'il-17
Taku et al. Gammaglobulin therapy in a case of chronic relapsing dysimmune polyneuropathy
RU2197990C2 (ru) Способ лечения лиц, страдающих от сепсиса
AU2002248189B2 (en) Methods for treating disease states comprising administration of low levels of antibodies
RU2772202C2 (ru) Лечение гнойного гидраденита
US4742076A (en) Etodolac for lowering rheumatoid factor
TW202535943A (zh) 改善抗ＦｃＲｎ療法之方法
JP2024516019A (ja) 抗ｂａｆｆｒ抗体を使用する全身性エリテマトーデスのための治療
WO2007105910A1 (fr) Composition pharmaceutique pour le traitement de maladies allergiques et de maladies inflammatoires chroniques, et procédé de traitement de maladies allergiques et de maladies inflammatoires chroniques
Buemi et al. Treatment of the nephritic syndrome in elderly with human intravenous immunoglobulins
TH2101002581A (th) วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn
AU2002248189A1 (en) Methods for treating disease states comprising administration of low levels of antibodies

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20121005